Ken Igawa

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

Emma Guttman‐Yassky, Eric L. Simpson, Kristian Reich et al. · The Lancet · 2022 · 153 citations

Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis, Immunology +7

11β-Hydroxysteroid Dehydrogenase-1 Is a Novel Regulator of Skin Homeostasis and a Candidate Target for Promoting Tissue Repair

Mika Terao, Hiroyuki Murota, Akihiro Kimura et al. · PLoS ONE · 2011 · 77 citations · Full text

Topical Application, Dermatology, Oxidative Stress +21

Dendritic Cells Express Hematopoietic Prostaglandin D Synthase and Function as a Source of Prostaglandin D2 in the Skin

Chieko Shimura, Takahiro Satoh, Ken Igawa et al. · American Journal Of Pathology · 2009 · 65 citations · Full text

Impaired Expression of Tim-3 on Th17 and Th1 Cells in Psoriasis

Yuko Kanai, Takahiro Satoh, Ken Igawa et al. · Acta Dermato Venereologica · 2012 · 47 citations · Full text

Regulatory mechanisms of galectin‐9 and eotaxin‐3 synthesis in epidermal keratinocytes: possible involvement of galectin‐9 in dermal eosinophilia of Th1‐polarized skin inflammation

Ken Igawa, Takahiro Satoh, Mitsuomi Hirashima et al. · Allergy · 2006 · 42 citations